FMA Advisory’s Teva Pharmaceuticals TEVA Stock Holding History

FMA Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$80K	Buy	+1,352	New	+$83.4K	0.05%	160
2014 Q4	–	Sell	-10,036	Closed	-$539K	–	134
2014 Q3	$539K	Buy	+10,036	New	+$532K	0.2%	115
2014 Q1	–	Sell	-11,624	Closed	-$466K	–	127
2013 Q4	$466K	Sell	11,624 -2,953	-20%	-$116K	0.19%	109
2013 Q3	$551K	Sell	14,577 -2,450	-14%	-$95.6K	0.22%	118
2013 Q2	$667K	Buy	+17,027	New	+$663K	0.28%	108

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

FMA Advisory's TEVA Position: Q2 2015 in Review

FMA Advisory opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2015: 1,352 shares worth $80K. The stake represents 0.05% of the portfolio and ranks #160 among its holdings. This is a return to the name: FMA Advisory previously reported a position in TEVA as recently as Q3 2014.

FMA Advisory first reported a position in TEVA in Q2 2013 and has held it in 5 quarters since. The position peaked at $667K in Q2 2013. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

FMA Advisory held 1,352 shares of Teva Pharmaceuticals worth $80K as of Q2 2015.
Teva Pharmaceuticals was a new FMA Advisory position in Q2 2015.
Teva Pharmaceuticals made up 0.05% of FMA Advisory's portfolio in Q2 2015, its #160 holding.
FMA Advisory first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
FMA Advisory's Teva Pharmaceuticals position peaked at $667K in Q2 2013.
818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on FMA Advisory's 13F filing for Q2 2015, filed 17 Dec 2019.